Home|Journals|Articles by Year|Audio Abstracts
 

Original Research

J Complement Med Res. 2016; 5(3): 335-340


Animal Study of Effect of Lamotrigine Pretreatment in Bipolar Disorder

V. M. Thorat, Anjali Ravindra Shinde, Sheshla Sadanandan, Pritam M. Sakhare, P. S. Salve, D. A. Mane.




Abstract

In the present study treatment with high doses of dexamphetamine (5 and 10 mg/kg ip) as well as apomorphine (1.5 and 3 mg/kg ip) was found to induce sniffing and oral movement variety (OMV) of stereotyped behaviour (SB) in rats. Pretreatment with haloperidol antagonised the SB induced by lamotrigine and that induced by apomorphine and dexamphetamine. This indicates that DAergic mechanisms are involved in the induction of SB by lamotrigine in rats. Pretreatment with alpha-methyl-p-tyrosine results in depletion of both DA and noradrenaline from the DAergic and noradrenergic neurons respectively whereas pretreatment with small doses of apomorphine cause selective depletion of DA from the DAergic neurons. Further, the intensity of haloperidol catalepsy depends on the dose of haloperidol used, increasing with increase in dose. The effect of pretreatment with small doses of apomorphine was therefore studied on the SB induced by lamotrigine, apomorphine and dexamphetamine. The results were statistically analyzed based on student’s t-test.

Key words: Haloperidol, Lamotrigine, Phenyltriazine, Bipolar depression, Neurotransmitter, Cataleptic disorder, Antiepileptic stabilizer






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.